About Srushti Pharmaceuticals Private Limited
Data last updated:
Srushti Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA1985PTC007272. Its GSTIN is 29AABCS7728R1ZF (Karnataka).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹6.76 Lakh. It is led by directors Mayuri Jatish Sheth and Jatish Sheth.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 154 10th Main 3rd Phase Peenya, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.26 Cr, a decline of 56% compared to the previous year. For the same year it recorded a net profit of ₹33.46 Lakh (net margin 14.8%) and EBITDA of ₹37.26 Lakh (EBITDA margin 16.5%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 2% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Srushti Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹3.08 Cr on record. Court records list 13 cases involving the company, including 3 filed by the company and 10 filed against it; 5 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srushtipharma.com.
Company details
CIN history
Srushti Pharmaceuticals has one previous CIN (Corporate Identification Number): U24119KA1985PTC007272. The current CIN is U24230KA1985PTC007272, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230KA1985PTC007272 | Current |
| U24119KA1985PTC007272 | Previous |
Contact details
Srushti Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its website is srushtipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address154 10th Main 3rd Phase Peenya, Bangalore, Karnataka, India – 560058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srushti Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Srushti Pharmaceuticals operates one associated brand: Srushti Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of sustained release formulations and drug delivery systems in India. | srushtipharma.com |
Business activity
The main business activity of Srushti Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Srushti Pharmaceuticals Private Limited, buy the company report.
Financials of Srushti Pharmaceuticals Private Limited
FY 2024 filings availableSrushti Pharmaceuticals Private Limited reported revenue of ₹2.26 Cr (down 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 56% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹37.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.5% | ||||
| Net Profit Margin | 14.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srushti Pharmaceuticals Private Limited, buy the company report.
Board of directors of Srushti Pharmaceuticals Private Limited
Srushti Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayuri Jatish Sheth Also directs: Meganza Pharma LLP | Director | 12 May 2014 | 12 Years 5 Months | Current |
| Jatish Sheth Also directs: Meganza Pharma LLP, Bal Pharma Limited | Director | 08 Nov 1985 | 40 Years 11 Months | Current |
Peer comparison
Srushti Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Euploid Pharmaceuticals Private Limited | ₹2.26 Cr (FY 2025) | 276.0% | Bangalore, Karnataka, India | |||
| Globentis International Private Limited | ₹2.26 Cr (FY 2025) | -7.0% | Ahmedabad, Gujarat, India | |||
| Srushti Pharmaceuticals Private Limitedthis company | ₹2.26 Cr (FY 2025) | ₹33.46 Lakh | 14.8% | -56.0% | 13 | Bangalore, Karnataka, India |
| Anandeshwar Chemtech Private Limited | ₹2.25 Cr (FY 2025) | Bhadrsa, Uttar Pradesh, India |
To see the full peer comparison of Srushti Pharmaceuticals Private Limited, buy the company report.
Auditor
Srushti Pharmaceuticals Private Limited is audited by ADITYA B N & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ADITYA B N & CO | FY 2024 | 014093S |
Shareholding
The shareholding of Srushti Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Srushti Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 May 2008 | 10112247 | State Bank of India | ₹3.08 Cr | Satisfied |
To see the full charge records of Srushti Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Srushti Pharmaceuticals Private Limited has 13 court cases on record: 3 filed by Srushti Pharmaceuticals, 10 filed against it. 5 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 9 | 5 |
| High courts | 2 | 0 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0104-Labour Matters : Matters relating to wages, bonus, ad-hoc, casual daily wages & their regularisation) | Filed against the company by Group Pharmaceuticals Ltd. Managing Directors 521/A, 2Nd Block, 2Nd Main 2Nd Stage Rajaji Nagar Bengaluru-560055 ,Bangalore , Karnataka and 10 others | Disposed |
| District court, BENGALURU, Karnataka | Execution petition | Filed against the company by M/S B V Aswathaiah and Brothers | Pending |
| District court, BENGALURU, Karnataka | Court case (ID) | Filed against the company by an individual | Pending |
| District court, BENGALURU, Karnataka | Court case (ID) | Filed against the company by an individual | Pending |
| District court, BENGALURU, Karnataka | Court case (ID) | Filed against the company by an individual | Pending |
To see the full case history of Srushti Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Srushti Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Merieux Nutrisciences Bangalore Private Limited |
To see the full MSME payment records of Srushti Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Srushti Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Mar 26, 2025, across 1 active EPFO establishment.
GST
Srushti Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCS7728R1ZF | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Srushti Pharmaceuticals Private Limited, buy the company report.
Recent activity
Srushti Pharmaceuticals Private Limited has 5 board changes on record since 1985: 2 appointments and 3 cessations. The latest: Mayuri Jatish Sheth ceased to be Additional Director on 30 Sep 2014.
Frequently asked questions
Srushti Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 1985 (41+ years old) and is registered under CIN U24230KA1985PTC007272.
Srushti Pharmaceuticals has 2 current directors:
- Mayuri Jatish Sheth - Director
- Jatish Sheth - Director
The latest financial statements of Srushti Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Srushti Pharmaceuticals is 29AABCS7728R1ZF, registered in Karnataka.
The CIN (Corporate Identification Number) of Srushti Pharmaceuticals is U24230KA1985PTC007272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srushti Pharmaceuticals has 13 court cases on record: 3 filed by the company and 10 filed against it. 5 are pending. Most are in the district courts.
Srushti Pharmaceuticals was incorporated on 08 November 1985, making it 41+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Srushti Pharmaceuticals by revenue are Euploid Pharmaceuticals Private Limited, Globentis International Private Limited, Anandeshwar Chemtech Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayuri Jatish Sheth ceased to be Additional Director on 30 Sep 2014. Kantharaj Sriramaiah Boggaram ceased to be Director on 12 May 2014. Mayuri Jatish Sheth was appointed as Director on 12 May 2014. Srushti Pharmaceuticals has 5 board changes on record in total.
Srushti Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 16 Jul 2019.
Srushti Pharmaceuticals can be reached through the website srushtipharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Srushti Pharmaceuticals is at 154 10th Main 3rd Phase Peenya, Bangalore, Karnataka, India – 560058.